172 related articles for article (PubMed ID: 28917021)
21. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
22. Second primary gynecologic cancers after breast cancer in Turkish women.
Gulhan I; Eser S; Yakut C; Bige O; Ilhan E; Yildirim Y; Saygili U
Int J Gynecol Cancer; 2009 May; 19(4):648-50. PubMed ID: 19509564
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer clinical characteristics and outcomes in Trinidad and Tobago.
Camacho-Rivera M; Ragin C; Roach V; Kalwar T; Taioli E
J Immigr Minor Health; 2015 Jun; 17(3):765-72. PubMed ID: 24146313
[TBL] [Abstract][Full Text] [Related]
24. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology.
Viikki M; Pukkala E; Hakama M
Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765
[TBL] [Abstract][Full Text] [Related]
25. Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database.
Kim DS; Ahn HS; Kim HJ
Int J Cancer; 2022 Apr; 150(7):1156-1165. PubMed ID: 34751444
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of gynecologic cancers in China.
Jiang X; Tang H; Chen T
J Gynecol Oncol; 2018 Jan; 29(1):e7. PubMed ID: 29185265
[TBL] [Abstract][Full Text] [Related]
28. Risk of Gynecologic Cancer According to the Type of Endometriosis.
Saavalainen L; Lassus H; But A; Tiitinen A; Härkki P; Gissler M; Pukkala E; Heikinheimo O
Obstet Gynecol; 2018 Jun; 131(6):1095-1102. PubMed ID: 29742675
[TBL] [Abstract][Full Text] [Related]
29. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S):S1-S9. PubMed ID: 30819761
[TBL] [Abstract][Full Text] [Related]
30. National and Subnational Trends of Incidence and Mortality of Female Genital Cancers in Iran; 1990-2016.
Eftekharzadeh S; Ebrahimi N; Samaei M; Mohebi F; Mohajer B; Sheidaei A; Gohari K; Saeedi Moghaddam S; Ahmadi N; Mohammadi Fateh S; Ramezani Tehrani F; Farzadfar F
Arch Iran Med; 2020 Jul; 23(7):434-444. PubMed ID: 32657594
[TBL] [Abstract][Full Text] [Related]
31. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
32. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
33. EQ-5D-5L population norms and health inequalities for Trinidad and Tobago.
Bailey H; Janssen MF; La Foucade A; Kind P
PLoS One; 2019; 14(4):e0214283. PubMed ID: 31034491
[TBL] [Abstract][Full Text] [Related]
34. Cancer incidence and mortality in the Caribbean.
Phillips AA; Jacobson JS; Magai C; Consedine N; Horowicz-Mehler NC; Neugut AI
Cancer Invest; 2007 Sep; 25(6):476-83. PubMed ID: 17882661
[TBL] [Abstract][Full Text] [Related]
35. Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
Nakai H; Higashi T; Kakuwa T; Matsumura N
Int J Clin Oncol; 2024 Apr; 29(4):363-371. PubMed ID: 38381162
[TBL] [Abstract][Full Text] [Related]
36. The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
Modesitt SC; van Nagell JR
Obstet Gynecol Surv; 2005 Oct; 60(10):683-92. PubMed ID: 16186785
[TBL] [Abstract][Full Text] [Related]
37. Risk for colorectal cancer after gynecologic cancer.
Weinberg DS; Newschaffer CJ; Topham A
Ann Intern Med; 1999 Aug; 131(3):189-93. PubMed ID: 10428735
[TBL] [Abstract][Full Text] [Related]
38. National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias.
Fanning J; Gangestad A; Andrews SJ
Gynecol Oncol; 2000 Jun; 77(3):450-3. PubMed ID: 10831358
[TBL] [Abstract][Full Text] [Related]
39. Trends in breast cancer mortality in Trinidad and Tobago--a 35-year study.
Naraynsingh V; Hariharan S; Dan D; Bhola S; Bhola S; Nagee K
Cancer Epidemiol; 2010 Feb; 34(1):20-3. PubMed ID: 19963444
[TBL] [Abstract][Full Text] [Related]
40. Trinidad and Tobago.
United States. Department of State. Bureau of Public Affairs
Backgr Notes Ser; 1989 Apr; ():1-7. PubMed ID: 12178003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
